A phase I study of ABT-510 plus bevacizumab in advanced solid tumors

Autoria(s): Uronis, HE; Cushman, SM; Bendell, JC; Blobe, GC; Morse, MA; Nixon, AB; Dellinger, A; Starr, MD; Li, H; Meadows, K; Gockerman, J; Pang, H; Hurwitz, HI
Data(s)

01/06/2013
Formato

316 - 324
Identificador

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000209210700006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92

CANCER MEDICINE, 2013, 2 (3), pp. 316 - 324

2045-7634

http://hdl.handle.net/10161/11086
Relação

CANCER MEDICINE

10.1002/cam4.65
Palavras-Chave #ABT-510 #advanced solid tumors #bevacizumab #phase I
Tipo

Journal Article
Acesso ao item digital